Grant: Alliance Grants
University of Toronto
$129,265.00
Robust quantification of high-dimensional cell phenotypes from human tissues
EF 2024-25
Résumé
Quantification of high dimensional cellular phenotypes from human tissues is key both for the prediction of patient outcomes as well as basic modern biomedical research. Recent technological advances have created the ability to profile the expression of >40 proteins across large areas of tissues in a sufficiently rapid turnaround to be of use for making clinical decisions. However, before this promise can be realized, many technical barriers remain. Firstly, imaging artifacts such as tissue folds affect the quantification of cell types and no automated quality control solutions for these currently exist. Secondly, recent advances in tissue imaging now measure millions of cells at a resolution not compatible with existing cell segmentation or phenotyping algorithms. Finally, no end-to-end proof-of-concept workflows that go from tissue data through to automated and robust reporting of cellular phenotypes has been attempted prospectively using these systems. To address these challenges, this project will develop an innovative set of computational methodology resulting in a unique digital platform capable of robust quantification of single-cell phenotypes from whole-slide highly multiplexed imaging. Specifically, it will (i) develop machine learning methods for automated quality control and artifact removal, (ii) develop methods for mapping cellular phenotypes across multiple resolutions and scales, and (iii) validate the platform's utility to create digital reports for tumour boards. Together, this project will validate the overall workflow of whole tissue highly multiplexed imaging as a usable and robust next generation patient biomarker.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
598293-2024
Name nom
Campbell, Kieran KR
Department département
Molecular Genetics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
129265
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
9018
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Genomics, Proteomics, And Bioinformatics
Research subject fr
Génomique, Protéomique et Bioinformatique
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Robust quantification of high-dimensional cell phenotypes from human tissues
Keywords
bioinformatics; cellular phenotyping; highly mutliplexed imaging; spatial biology; statistical modelling
Application summary
Quantification of high dimensional cellular phenotypes from human tissues is key both for the prediction of patient outcomes as well as basic modern biomedical research. Recent technological advances have created the ability to profile the expression of >40 proteins across large areas of tissues in a sufficiently rapid turnaround to be of use for making clinical decisions. However, before this promise can be realized, many technical barriers remain. Firstly, imaging artifacts such as tissue folds affect the quantification of cell types and no automated quality control solutions for these currently exist. Secondly, recent advances in tissue imaging now measure millions of cells at a resolution not compatible with existing cell segmentation or phenotyping algorithms. Finally, no end-to-end proof-of-concept workflows that go from tissue data through to automated and robust reporting of cellular phenotypes has been attempted prospectively using these systems. To address these challenges, this project will develop an innovative set of computational methodology resulting in a unique digital platform capable of robust quantification of single-cell phenotypes from whole-slide highly multiplexed imaging. Specifically, it will (i) develop machine learning methods for automated quality control and artifact removal, (ii) develop methods for mapping cellular phenotypes across multiple resolutions and scales, and (iii) validate the platform's utility to create digital reports for tumour boards. Together, this project will validate the overall workflow of whole tissue highly multiplexed imaging as a usable and robust next generation patient biomarker.